Chiesi Farmaceutici originated in Parma in 1935 as a pharmacy.
Today, we are an international company based in Parma, with more than 80 years of experience and a strong focus on research, development, production and commercialisation of innovative medicines in the Respiratory, Neonatology, Rare Disease and Special Care Therapeutic Areas.
With a turnover of more than €1.6 billion sales we are among the top 50 pharmaceutical companies in the world. Our production sites are in Parma, (Italy), Blois (France) and Santana De Parnaiba (Brazil).
The R&D centres in Parma (Italy), Paris (France), Cary (USA), Chippenham and Oxford (UK), Hilerod (Denmark) and Lidingo (Sweden), integrate their efforts to advance Chiesi's pre-clinical, clinical and registration programmes.
We export to more than 70 countries with a direct presence in 27.
The Chiesi Group employs approximately 5,300 people, 720 of whom are dedicated to R&D activities and 751 of whom work at production sites.